Elanco Animal Health Incorporated Stock Analysis & AI Score
Elanco Animal Health Incorporated (ELAN) has an ST Score of 44.3 (C+), driven by its Profitability (A-) and held back by its Momentum (D). Analysts rate it Buy with a $28.00 price target (+25.2% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NYSE |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Elanco Animal Health Incorporated (ELAN) has an ST Score of 44.3 (C+), driven by its Profitability (A-) and held back by its Momentum (D). Analysts rate it Buy with a $28.00 price target (+25.2% upside).
- Strongest
- ProfitabilityA-
- Weakest
- MomentumD
All factor grades
- ProfitabilityA-
- ForecastB-
- GrowthC+
- ValuationC-
- Financial StrengthD
- MomentumD
- Piotroski5/9
Contact
ELAN stock: frequently asked questions
What is ELAN's ST Score?
Elanco Animal Health Incorporated (ELAN) has an ST Score of 44.3 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is ELAN a buy, hold, or sell?
Analysts rate ELAN a Buy, with a price target of $28.00 (+25.2% vs the current price). Our ST Score grades it C+ (44.3/100). The ST Score is a data-driven signal, not a recommendation.
What are ELAN's factor grades?
Valuation C-, Profitability A-, Financial Strength D, Momentum D, Growth C+, Forecast B-.
What is ELAN's valuation grade?
Elanco Animal Health Incorporated (ELAN) earns a valuation grade of C-, measured against Drug Manufacturers - Specialty & Generic peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is ELAN's growth grade?
Elanco Animal Health Incorporated (ELAN) earns a growth grade of C+, measured against Drug Manufacturers - Specialty & Generic peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is ELAN's profitability grade?
Elanco Animal Health Incorporated (ELAN) earns a profitability grade of A-, measured against Drug Manufacturers - Specialty & Generic peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is ELAN's financial strength grade?
Elanco Animal Health Incorporated (ELAN) earns a financial strength grade of D, measured against Drug Manufacturers - Specialty & Generic peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for ELAN?
The average analyst price target for Elanco Animal Health Incorporated (ELAN) is $28.00 from 21 analysts, which is +25.2% versus the recent price of $22.36.
What is ELAN's Piotroski score?
Elanco Animal Health Incorporated (ELAN) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.